$5.42 +0.07 (%) Alliqua BioMedical Inc - NASDAQ

Jul. 2, 2015 | 03:59 PM

Partner Headlines

  1. Benzinga's Top Initiations

    Benzinga | Jun. 26, 2015 | 09:41AM EST
  2. Alliqua BioMedical, Inc. Announces the Publication of Results From a Biovance(R) Use Registry Study in WOUNDS

    Benzinga | Jun. 25, 2015 | 07:35AM EST
  3. Market Overlooks Alliqua's First MAC Coverage

    GuruFocus | Apr. 21, 2015 | 10:27AM EST
  4. Celleration Acquisition Just the Start of Alliqua's M&A Strategy

    GuruFocus | Feb. 4, 2015 | 14:18PM EST
  5. Morning Market Gainers

    Benzinga | Feb. 3, 2015 | 09:45AM EST
  6. H.C. Wainwright's 8 Healthcare Stock Picks

    Benzinga | Jan. 13, 2015 | 07:08AM EST
  7. Alliqua BioMedical, Inc.'s Biovance Assigned Level II HCPCS Q Code for Product Reimbursement

    Benzinga | Nov. 3, 2014 | 07:31AM EST
  8. Abstract On Alliqua's Biovance Product To Receive Award At The Fall 2014 Symposium On Advanced Wound Care

    Benzinga | Oct. 13, 2014 | 07:30AM EST
  9. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 24, 2014 | 10:04AM EST
  10. Events for the Week of Sept. 8-12

    Benzinga | Sep. 10, 2014 | 14:34PM EST
  11. UPDATE: Ascendiant Capital Markets Initiates Coverage On Alliqua As Turnaround Story Warrants Fresh Look

    Benzinga | Jun. 4, 2014 | 09:38AM EST
  12. Alliqua to Launch Biovance, Manufactured by Celgene Subsidiary

    Benzinga | Apr. 23, 2014 | 07:33AM EST
  13. Alliqua Biomedical Announces New Data on sorbion(R) Wound Care Dressings to be Presented at the Spring 2014 SAWC Meeting

    Benzinga | Apr. 21, 2014 | 07:32AM EST
  14. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 9, 2014 | 10:17AM EST
  15. Alliqua Enters License Agreement with Celgene

    Benzinga | Nov. 19, 2013 | 07:39AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!